These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28433702)

  • 1. Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis.
    Heath PT; Culley FJ; Jones CE; Kampmann B; Le Doare K; Nunes MC; Sadarangani M; Chaudhry Z; Baker CJ; Openshaw PJM
    Lancet Infect Dis; 2017 Jul; 17(7):e223-e234. PubMed ID: 28433702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal immunisation: collaborating with mother nature.
    Marchant A; Sadarangani M; Garand M; Dauby N; Verhasselt V; Pereira L; Bjornson G; Jones CE; Halperin SA; Edwards KM; Heath P; Openshaw PJ; Scheifele DW; Kollmann TR
    Lancet Infect Dis; 2017 Jul; 17(7):e197-e208. PubMed ID: 28433705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization during pregnancy.
    Loubet P; Anselem O; Launay O
    Expert Rev Vaccines; 2018 May; 17(5):383-393. PubMed ID: 29715051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
    Munoz FM
    Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnant women's knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines.
    Giles ML; Buttery J; Davey MA; Wallace E
    Vaccine; 2019 Oct; 37(44):6743-6749. PubMed ID: 31540809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of neonates and infants by maternal immunization.
    Gerdts V; van Drunen Littel-van den Hurk S; Potter A
    Expert Rev Vaccines; 2016 Nov; 15(11):1347-1349. PubMed ID: 27248694
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants.
    Rainisch G; Adhikari B; Meltzer MI; Langley G
    Vaccine; 2020 Jan; 38(2):251-257. PubMed ID: 31740097
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model.
    Blanco JCG; Pletneva LM; McGinnes-Cullen L; Otoa RO; Patel MC; Fernando LR; Boukhvalova MS; Morrison TG
    Nat Commun; 2018 May; 9(1):1904. PubMed ID: 29765035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics.
    Vekemans J; Moorthy V; Giersing B; Friede M; Hombach J; Arora N; Modjarrad K; Smith PG; Karron R; Graham B; Kaslow DC
    Vaccine; 2019 Nov; 37(50):7394-7395. PubMed ID: 29395536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody.
    Englund JA
    Pediatr Infect Dis J; 1994 May; 13(5):449-53. PubMed ID: 8072835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus seasonality and its implications on prevention strategies.
    Janet S; Broad J; Snape MD
    Hum Vaccin Immunother; 2018 Jan; 14(1):234-244. PubMed ID: 29194014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
    Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
    Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    Binjawadagi B; Ma Y; Binjawadagi R; Brakel K; Harder O; Peeples M; Li J; Niewiesk S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challenge.
    Welliver RC; Papin JF; Preno A; Ivanov V; Tian JH; Lu H; Guebre-Xabier M; Flyer D; Massare MJ; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2020 Jan; 38(5):1258-1270. PubMed ID: 31761502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
    Green CA; Sande CJ; Scarselli E; Capone S; Vitelli A; Nicosia A; Silva-Reyes L; Thompson AJ; de Lara CM; Taylor KS; Haworth K; Hutchings CL; Cargill T; Angus B; Klenerman P; Pollard AJ
    J Infect; 2019 May; 78(5):382-392. PubMed ID: 30742894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal vaccines.
    Glezen WP
    Prim Care; 2001 Dec; 28(4):791-806, vi-vii. PubMed ID: 11739030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced age.
    Guichelaar T; Hoeboer J; Widjojoatmodjo MN; Reemers SS; van Els CA; Otten R; van Remmerden Y; Boes J; Luytjes W
    J Virol; 2014 Sep; 88(17):9744-50. PubMed ID: 24920795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.